Demonstration of Two Components and Association of Adenosine Diphosphate-Cytidine Diphosphate Reductase from Cultured Human Lymphoblast Cells (Molt-4F)

Total Page:16

File Type:pdf, Size:1020Kb

Demonstration of Two Components and Association of Adenosine Diphosphate-Cytidine Diphosphate Reductase from Cultured Human Lymphoblast Cells (Molt-4F) [CANCER RESEARCH 39, 436-442, February 1979] 0008-5472/79/0039-0000$02.00 Demonstrationof Two Components and Association of Adenosine Diphosphate-CytidineDiphosphate Reductase from Cultured Human LymphoblastCells (Molt-4F)1 Chi-Hsiung Chang and Yung-chi Cheng2 Department of Experimental Therapeutics, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14263 ABSTRACT Under the influence of different activators, the same en zyme molecule is capable of catalyzing the reduction of all Ribonucleotide meductase was isolated from a human 4 natural mibonucleotides at the diphosphate level (20). lymphoblast line (Molt-4F). Most of the meductase activity The enzyme obtained from mammalian cells has not been was present in the cytosol fraction. Two components (A and completely described due to difficulties in purification. B) were found which were readily separable by deoxy Studies of some properties of the partially purified enzyme guanosine triphosphate Sepharose column chromatogma derived from matNovikoff hepatoma (22, 23), Ehnlich ascites phy. Only Component B was retained on this column and cells (13), rabbit bone marrow (18) and regenerating rat could be eluted by high concentrations of KCI. Components liven (19) have been reported. More than one subunit has A and B were purified further by blue Sepharose, diethyl been shown for the enzyme derived from rabbit bone aminoethyl cellulose and phenyl-Sephamose column chro marrow (18), matNovikoff hepatoma (23), and Ehnlich ascites matography, as well as by sucrose gradient sedimentation. cells (12). The possible existence of different enzymes The apparent molecular weights estimated by sucrose gra responsible for the reductions of ADP and COP has been dient sedimentation were 100,000 for both Components A proposed in the case of Chinese hamster cells (24), rat and B, and 210,000 for the nondissociated mibonucleotide regenerating liven (10), and Ehmlich ascites cells (13). No reductase. The cytidine diphosphate (COP) and adenosine detailed study of the isolation and properties of nibonucIe diphosphate (AOP) reductase activities cochnomatogmaphed otide reductase from human origin has been reported. throughout the purification procedure with a constant ratio Because this enzyme has the potential of being a target for of 1.73 ±0.19 (5.0.) Variation of the ratio of purified cancer chemotherapy, we have undertaken the study of the Component A to B led to subsequent variation in overall properties of the enzyme derived from a cultured human activity. However, the ratio of COP to AOP enzyme activity lymphoblast cell line (Molt-4F). In this communication, we remained constant. The enzyme activities of reconstituted demonstrate that the enzyme consists of at least 2 compo purified A and B components were further characterized nents and that the ADP and COP meductaseactivities were with reference to cation requirements. Of those divalent associated throughout the purification procedure. We also cations tested, magnesium ion was found to be essential describe some of the properties of the 2 components. A for maximal enzyme activity, while calcium ion gave only preliminary report of this work has appeared previously (5). partial activation. Addition of zinc or manganese ion, at concentrations higher than 0.4 mM, to the reaction mixture MATERIALSAND METHODS containing 6 mM MgCl2 caused a marked inhibition of the enzyme activity for both ADP and CDP reduction. Spermi The sodium salts of COP, ADP, ATP, and dGTP; DTT,3 dine and spemmine can partially replace the MgCI2 require HEPES, pymuvatekinase, lactic dehydrogenase, and hemo ment for COP and ADP reduction. The optimal concentra globin were all purchased from Sigma Chemical Co. , St. tions of MgCl2 and dithiothreitol were 6 and 3 mM, mespec Louis, Mo. Ammonium salts of all 14C-labeled nucleotides tively. were supplied by Amersham/Seamle Corp. , Arlington Heights, Ill. Oowex 1-Cl was obtained from Bio-Rad Labo natory, Richmond, Va. All materials required for cell cul INTRODUCTION tunes were from Grand Island Biological Co. , Grand Island, Ribonucleotide reductase is the key enzyme responsible N. Y. All other chemicals were of reagent grade. dGTP for the synthesis of deoxynibonucleotides via the direct Sepharose was generously provided by Hoffmann and Blak reduction of mibonucleotides. The enzyme from Escherichia ley (16). Blue Sepharose, DEAE-celiulose, and phenyl coli has been purified and well characterized (2, 17, 27). It Sephanose were purchased from Pharmacia Fine Chemi is made of 2 nonidentical subunits, B1 and B2, both of cals, Piscataway, N. J. which are required to form the enzymatically active complex Culture Conditions. Molt-4F cells, which were isolated in the presence of magnesium ion (4). The enzyme contains from peripheral blood of acute lymphocytic leukemia pa nonheme iron which is essential for enzyme activity (3). tients, were cultured in 1-liter spinner flasks with Roswell Park Memorial Institute Medium 1640 containing 5% heat inactivated fetal calf serum, penicillin (100 units/mI), and 1 This work was supported by USPHS Project Grant CA-18499 and Core stneptomycin sulfate (100 @g/ml).The cells were maintained Grant CA-13038 from the National Cancer Institute. 2 An American Leukemia Society Scholar. To whom requests for reprints should be addressed. 3 The abbreviations used are: DTT, dithiothreitol; HEPES, 4-(2-hydroxy Received June 5, 1978: accepted November 3, 1978. ethyl)-1-piperazmneethanesultOnic acid. 436 CANCER RESEARCH VOL. 39 Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 1979 American Association for Cancer Research. Two Ribonuc!eotide Reductase Components from Lymphob!ast Ce!!s in the log phase of growth by feeding the cultures with an with 25 strokes in a Dounce homogenizer. The homogenate equal volume of the fresh medium every 24 hr. The cultured was centrifuged at 100,000 x g for 60 mm, and the super cells were harvested by centnifugation and washed 6 times natant (16 ml) was used immediately in the next purification with phosphate-buffered saline (pH 7.2, 1 liter containing step. 0.1 g CaCI2, 0.2 g KCI, 0.2 g KH2PO4,0.1 g MgCl2•6H20,8g StreptomycinSulfate Fractionation.A solutionof strep NaCI, and 2.16 g Na2HPO4•7H20).Afterthis treatment, the tomycin sulfate (20%, w/v) was added dropwise to the cells were stored at —70°untilneeded. crude extract (16 ml) to yield a final concentration of 1%. Enzyme Assay. COP reductase was assayed by the The solution was stirred for 20 mm at 4°,andthe precipitate method of Steepen and Steuart (25) with the use of Dowex was removed by centnifugation at 10,000 x g for 20 mm. 1-borate ion-exchange chromatography. The assay mixture The supemnatant (16 ml) was used in the following step. contained, in a final volume of 0.2 ml, [‘4CJCOP(0.2pCi; Ammonium Sulfate Fractionation. Ammonium sulfate 0.15 mM), OTT (3 mM), MgCI2 (6 mM), ATP (5 mM), and a was added to the supemnatant obtained from the previous specified amount of the enzyme. AOP neductase activity step to 35% saturation. After a stirring at 4°for 30 mm, the was determined by the method of Conyet a!. (14). The assay suspension was centrifuged at 10,000 x g for 20 mm, and mixture contained, in a final volume of 0.2 ml, [‘4CJADP the precipitate was discarded. More ammonium sulfate was (0.22 pCi; 0.15 mM), OTT (3 mM), MgCI2 (6 mM), and dGTP added to the supennatant to give 50% saturation. After (5 mM), and a specified amount of the enzyme. An enzyme being stirred for another 30 mm, the precipitate was col sample heated for 2 mm in a boiling water bath prior to the lected by centnifugation and was dissolved in 4 ml of Buffer addition of the labeled substrate served as the reaction B. The enzyme solution was dialyzed overnight against the blank. The incubation was at 37°for 60 mm, and the same buffer. reaction was linear with respect to time and enzyme con Separation of Components A and B on dGTP-Sepharose centration during this incubation period. The inclusion of Chromatography.Thedialysate(4 ml) was madeto 10 mM ATP in the COP meductase assay and dGTP in the ADP with respect to NaF and loaded on a dGTP-Sephamose meductase assay was essential for COP and AOP meductase column (1.5 x 10 cm) previously equilibrated with Buffer B activities, respectively. The specificity of the activators for containing 10 mM NaF. The column was washed with the COP and ADP reductase activity will be reported in a same buffer until the absorbance at 280 nm was less than subsequent communication. A preliminary report of the 0.05. Four consecutive-step elutions were then performed kinetic behaviors of this enzyme has appeared previously with 0.5 mM dGTP, 50 mM KCI, 1 M KCI, and 2 M KCI in (6). The activities of Components A and B as shown in Buffer B as indicated in Chart 1. After dialysis against Buffer Charts 1 to 5 and Table 1 were determined by adding an C, the fractions were analyzed for protein concentration excess amount of B on A, respectively. The amount of and enzyme activity. No activity was detected in any of the Component A on B used to saturate the respective compo fractions collected. Fractions 3 to 12, 13 to 19, 20 to 26, 27 nent under investigation was sufficient to give a minimum to 31, and 32 to 38 were pooled and dialyzed overnight activity of 90 pmol COP reduced per mm penml and 50 pmol against Buffer C containing 30% sucrose. Various combi ADP reduced per mm per ml of Component A on B. These nations of each pooled fraction were assayed for both AOP components were obtained from the dGTP-Sephamose col and COP reductase activities.
Recommended publications
  • Nucleotide Metabolism 22
    Nucleotide Metabolism 22 For additional ancillary materials related to this chapter, please visit thePoint. I. OVERVIEW Ribonucleoside and deoxyribonucleoside phosphates (nucleotides) are essential for all cells. Without them, neither ribonucleic acid (RNA) nor deoxyribonucleic acid (DNA) can be produced, and, therefore, proteins cannot be synthesized or cells proliferate. Nucleotides also serve as carriers of activated intermediates in the synthesis of some carbohydrates, lipids, and conjugated proteins (for example, uridine diphosphate [UDP]-glucose and cytidine diphosphate [CDP]- choline) and are structural components of several essential coenzymes, such as coenzyme A, flavin adenine dinucleotide (FAD[H2]), nicotinamide adenine dinucleotide (NAD[H]), and nicotinamide adenine dinucleotide phosphate (NADP[H]). Nucleotides, such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), serve as second messengers in signal transduction pathways. In addition, nucleotides play an important role as energy sources in the cell. Finally, nucleotides are important regulatory compounds for many of the pathways of intermediary metabolism, inhibiting or activating key enzymes. The purine and pyrimidine bases found in nucleotides can be synthesized de novo or can be obtained through salvage pathways that allow the reuse of the preformed bases resulting from normal cell turnover. [Note: Little of the purines and pyrimidines supplied by diet is utilized and is degraded instead.] II. STRUCTURE Nucleotides are composed of a nitrogenous base; a pentose monosaccharide; and one, two, or three phosphate groups. The nitrogen-containing bases belong to two families of compounds: the purines and the pyrimidines. A. Purine and pyrimidine bases Both DNA and RNA contain the same purine bases: adenine (A) and guanine (G).
    [Show full text]
  • Central Nervous System Dysfunction and Erythrocyte Guanosine Triphosphate Depletion in Purine Nucleoside Phosphorylase Deficiency
    Arch Dis Child: first published as 10.1136/adc.62.4.385 on 1 April 1987. Downloaded from Archives of Disease in Childhood, 1987, 62, 385-391 Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency H A SIMMONDS, L D FAIRBANKS, G S MORRIS, G MORGAN, A R WATSON, P TIMMS, AND B SINGH Purine Laboratory, Guy's Hospital, London, Department of Immunology, Institute of Child Health, London, Department of Paediatrics, City Hospital, Nottingham, Department of Paediatrics and Chemical Pathology, National Guard King Khalid Hospital, Jeddah, Saudi Arabia SUMMARY Developmental retardation was a prominent clinical feature in six infants from three kindreds deficient in the enzyme purine nucleoside phosphorylase (PNP) and was present before development of T cell immunodeficiency. Guanosine triphosphate (GTP) depletion was noted in the erythrocytes of all surviving homozygotes and was of equivalent magnitude to that found in the Lesch-Nyhan syndrome (complete hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency). The similarity between the neurological complications in both disorders that the two major clinical consequences of complete PNP deficiency have differing indicates copyright. aetiologies: (1) neurological effects resulting from deficiency of the PNP enzyme products, which are the substrates for HGPRT, leading to functional deficiency of this enzyme. (2) immunodeficiency caused by accumulation of the PNP enzyme substrates, one of which, deoxyguanosine, is toxic to T cells. These studies show the need to consider PNP deficiency (suggested by the finding of hypouricaemia) in patients with neurological dysfunction, as well as in T cell immunodeficiency. http://adc.bmj.com/ They suggest an important role for GTP in normal central nervous system function.
    [Show full text]
  • Standard Abbreviations
    Journal of CancerJCP Prevention Standard Abbreviations Journal of Cancer Prevention provides a list of standard abbreviations. Standard Abbreviations are defined as those that may be used without explanation (e.g., DNA). Abbreviations not on the Standard Abbreviations list should be spelled out at first mention in both the abstract and the text. Abbreviations should not be used in titles; however, running titles may carry abbreviations for brevity. ▌Abbreviations monophosphate ADP, dADP ‌adenosine diphosphate, deoxyadenosine IR infrared diphosphate ITP, dITP ‌inosine triphosphate, deoxyinosine AMP, dAMP ‌adenosine monophosphate, deoxyadenosine triphosphate monophosphate LOH loss of heterozygosity ANOVA analysis of variance MDR multiple drug resistance AP-1 activator protein-1 MHC major histocompatibility complex ATP, dATP ‌adenosine triphosphate, deoxyadenosine MRI magnetic resonance imaging trip hosphate mRNA messenger RNA bp base pair(s) MTS ‌3-(4,5-dimethylthiazol-2-yl)-5-(3- CDP, dCDP ‌cytidine diphosphate, deoxycytidine diphosphate carboxymethoxyphenyl)-2-(4-sulfophenyl)- CMP, dCMP ‌cytidine monophosphate, deoxycytidine mono- 2H-tetrazolium phosphate mTOR mammalian target of rapamycin CNBr cyanogen bromide MTT ‌3-(4,5-Dimethylthiazol-2-yl)-2,5- cDNA complementary DNA diphenyltetrazolium bromide CoA coenzyme A NAD, NADH ‌nicotinamide adenine dinucleotide, reduced COOH a functional group consisting of a carbonyl and nicotinamide adenine dinucleotide a hydroxyl, which has the formula –C(=O)OH, NADP, NADPH ‌nicotinamide adnine dinucleotide
    [Show full text]
  • And Triphosphate from Royal Jelly Using Liquid Chromatography - Tandem Mass Spectrometry," Journal of Food and Drug Analysis: Vol
    Volume 28 Issue 3 Article 2 2020 Quantification of Adenosine Mono-, Di- and riphosphateT from Royal Jelly using Liquid Chromatography - Tandem Mass Spectrometry Follow this and additional works at: https://www.jfda-online.com/journal Part of the Food Science Commons, Medicinal Chemistry and Pharmaceutics Commons, Pharmacology Commons, and the Toxicology Commons This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License. Recommended Citation Liao, Wan-Rou; Huang, Jen-Pang; and Chen, Sung-Fang (2020) "Quantification of Adenosine Mono-, Di- and Triphosphate from Royal Jelly using Liquid Chromatography - Tandem Mass Spectrometry," Journal of Food and Drug Analysis: Vol. 28 : Iss. 3 , Article 2. Available at: https://doi.org/10.38212/2224-6614.1007 This Original Article is brought to you for free and open access by Journal of Food and Drug Analysis. It has been accepted for inclusion in Journal of Food and Drug Analysis by an authorized editor of Journal of Food and Drug Analysis. Quantification of adenosine Mono-, Di- and triphosphate from royal jelly using liquid chromatography - Tandem mass spectrometry ORIGINAL ARTICLE Wan-Rou Liao a, Jen-Pang Huang b, Sung-Fang Chen a,* a Department of Chemistry, National Taiwan Normal University, Taipei, Taiwan b MSonline Scientific Co., Ltd., Taipei, Taiwan Abstract Nucleotides are composed of nitrogen bases, ribose units and phosphate groups. Adenine (Ade), adenosine mono- phosphate (AMP), adenosine diphosphate (ADP) and adenosine triphosphate (ATP) all play important roles in physio- logical metabolism. Royal jelly, a secretion produced by worker bees, contains a variety of natural ingredients and several studies have shown that royal jelly can serve as a source of nutrition for humans.
    [Show full text]
  • Adenosine Diphosphate Glucose Pyrophosphatase: a Plastidial Phosphodiesterase That Prevents Starch Biosynthesis
    Adenosine diphosphate glucose pyrophosphatase: A plastidial phosphodiesterase that prevents starch biosynthesis Milagros Rodrı´guez-Lo´ pez, Edurne Baroja-Ferna´ ndez, Aitor Zandueta-Criado, and Javier Pozueta-Romero* Instituto de Agrobiotecnologı´ay Recursos Naturales, Universidad Pu´blica de Navarra ͞Consejo Superior de Investigaciones Cientı´ficas,Carretera de Mutilva s͞n, Mutilva Baja, 31192 Navarra, Spain Communicated by Andre´T. Jagendorf, Cornell University, Ithaca, NY, April 13, 2000 (received for review November 28, 1999) A distinct phosphodiesterasic activity (EC 3.1.4) was found in both their possible occurrence in several plant species. As a result, we mono- and dicotyledonous plants that catalyzes the hydrolytic have now found a phosphodiesterasic activity that catalyzes the breakdown of ADPglucose (ADPG) to produce equimolar amounts hydrolytic breakdown of ADPG. In this paper, we report of glucose-1-phosphate and AMP. The enzyme responsible for this the subcellular localization and biochemical characterization of activity, referred to as ADPG pyrophosphatase (AGPPase), was the enzyme responsible for this activity, referred to as ADPG purified over 1,100-fold from barley leaves and subjected to pyrophosphatase (AGPPase).† Based on the results presented in biochemical characterization. The calculated Keq؅ (modified equi- this work using different plant sources, we discuss that AGPPase librium constant) value for the ADPG hydrolytic reaction at pH 7.0 may be involved in controlling the intracellular levels of ADPG and 25°C is 110, and its standard-state free-energy change value linked to starch biosynthesis. kJ). Kinetic analyses showed 4.18 ؍ G؅)is؊2.9 kcal͞mol (1 kcal⌬) that, although AGPPase can hydrolyze several low-molecular Materials and Methods weight phosphodiester bond-containing compounds, ADPG Plant Material.
    [Show full text]
  • Utilization of L-Methionine and S-Adenosyl-L-Methionine for Methylation of Soluble RNA by Mouse Liver and Hepatoma Extracts1
    [CANCER RESEARCH 27, 646-«S3,April 1967] Utilization of L-Methionine and S-Adenosyl-L-methionine for Methylation of Soluble RNA by Mouse Liver and Hepatoma Extracts1 R. L. HANCOCK The Jackson Laboratory, Bar Harbor, Maine SUMMARY following reaction: ATP + L-methionine = SAM + pyrophos The methyl group of L-methionine or S-adenosyl-L-methionine phate + monophosphate (7). SAM is used in the methylation of sRNA by sRNA methylases in the following reaction: sRNA + is used by nonparticulate mouse liver and hepatoma prepara SAM = methylated sRNA + S-adenosyl-L-homocysteine (10). tions to methylate soluble ribonucleic acid (sRNA). Esclierichia The two enzyme reactions are presented along with a representa coli K12 sRNA was a more active substrate than yeast sRNA. tion of the origin of the unmethylated sRNA (tp-RNA) in Chart Four different lots of E. coli B sRNA gave similar incorporations between lots. "Stripped" and "nonstripped" sRNA had similar 1. An array of RNA methylases exhibiting specificity for par ticular bases and for sRNA from different biologic sources, along amounts of methyl incorporation. Other nucleoside triphosphates with other, less si^ecific RNA methylases, has been described besides adenosine triphosphate were capable of sup]x>rting the incorjioration of methyl groups from L-methionine into sRNA. (11, 15, 16, 17, 22). The most extensively methylated sRNA molecules known have been found in mammary adenocarcinoma The nonspecificity of the nucleoside triphosphate reaction was tissue (3), and recently Mittelman et al. (18) have found RNA shown to be due to an adenosine diphosphokinase reaction and methylase activity to be extremely high in certain viral-induced not to nucleoside tri phosphate: L-methionine nucleosidyl trans- tumor cells.
    [Show full text]
  • Guanosine-Based Nucleotides, the Sons of a Lesser God in the Purinergic Signal Scenario of Excitable Tissues
    International Journal of Molecular Sciences Review Guanosine-Based Nucleotides, the Sons of a Lesser God in the Purinergic Signal Scenario of Excitable Tissues 1,2, 2,3, 1,2 1,2, Rosa Mancinelli y, Giorgio Fanò-Illic y, Tiziana Pietrangelo and Stefania Fulle * 1 Department of Neuroscience Imaging and Clinical Sciences, University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy; [email protected] (R.M.); [email protected] (T.P.) 2 Interuniversity Institute of Miology (IIM), 66100 Chieti, Italy; [email protected] 3 Libera Università di Alcatraz, Santa Cristina di Gubbio, 06024 Gubbio, Italy * Correspondence: [email protected] Both authors contributed equally to this work. y Received: 30 January 2020; Accepted: 25 February 2020; Published: 26 February 2020 Abstract: Purines are nitrogen compounds consisting mainly of a nitrogen base of adenine (ABP) or guanine (GBP) and their derivatives: nucleosides (nitrogen bases plus ribose) and nucleotides (nitrogen bases plus ribose and phosphate). These compounds are very common in nature, especially in a phosphorylated form. There is increasing evidence that purines are involved in the development of different organs such as the heart, skeletal muscle and brain. When brain development is complete, some purinergic mechanisms may be silenced, but may be reactivated in the adult brain/muscle, suggesting a role for purines in regeneration and self-repair. Thus, it is possible that guanosine-50-triphosphate (GTP) also acts as regulator during the adult phase. However, regarding GBP, no specific receptor has been cloned for GTP or its metabolites, although specific binding sites with distinct GTP affinity characteristics have been found in both muscle and neural cell lines.
    [Show full text]
  • 31P NMR of ADENOSINE PHOSPHATES ANASAZI APPLICATION SERIES PAGE 2 of 4
    P 15 PHOSPHORUS ANASAZI APPLICATION SERIES BROADBAND PROBE / MULTINUCLEAR PROBE 31P NMR OF ADENOSINE PHOSPHATES ANASAZI APPLICATION SERIES PAGE 2 of 4 DID YOU KNOW? Adenosine phosphates are vital for all living organisms. The interconversion of adenosine diphosphate (ADP) and adenosine triphosphate (ATP) not only generates energy for your cells, but also stores energy for when you need it later. When a phosphate group is cleaved from ATP, energy is released and used by your cells. On the other hand your cells capture energy by synthesizing ATP. ATP is now free to move about the cell to other locations that need energy. As a result, the amount of ADP and ATP in a cell changes constantly. ATP and ADP’s little cousin, adenosine monophosphate (AMP) plays a role in this energy cycle. Interestingly enough, AMP is also used commercially as a ‘bitter blocker’, a food additive to alter human perception of taste. AMP is also in your RNA… weird huh? 31P NMR can be used to study the change in concentration of various phosphorus species in human muscles during exercise and rest. Using the 31P spectra of AMP, ADP, and ATP students learn how to interpret 31P NMR spectra of adenosine phosphates and use 31P NMR to determine the quantities of ADP and ATP in an unknown sample. NH2 N Adenosine N O O P O- Phosphates N N - O O AMP NH2 OH OH N N O O O P O P O- N N - - O O O ADP OH OH NH2 N N O O O O P O P O P O- N N - - - O O O O ATP OH OH 1 Friebolin, H.
    [Show full text]
  • The Effect of Thrombocytopenia on Experimental Arteriosclerotic Lesion Formation in Rabbits
    The Effect of Thrombocytopenia on Experimental Arteriosclerotic Lesion Formation in Rabbits SMOOTH MUSCLE CELL PROLIFERATION AND RE-ENDOTHELIALIZATION ROBERT J. FRIEDMAN, MICHAEL B. STEMERMAN, BARRY WENZ, SEAN MOORE, JACK GAULDIE, MICHAEL GENT, MELVIN L. TIELL, and THEODORE H. SPAET, Department of Medicine, Division of Hematology, Montefiore Hospital and Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, and Departments of Pathology and Clinical Epidemiology and Biostatistics, McMaster University, Faculty of Medicine, Hamilton, Ontario, Canada A B S TR A C T This study was designed to investigate INTRODUCTION the mechanisms involved in fibromusculoelastic lesion formation produced by selective de-endothelialization A knowledge of the interaction of platelets, smooth by the intra-arterial balloon catheter technique in muscle cells, and endothelium is of major significance thrombocytopenic rabbits. Thrombocytopenia was in- to an understanding of the mechanisms of the arterio- duced and maintained for up to 31 days by daily sclerotic process. When the endothelium of an artery injections of highly specific sheep anti-rabbit platelet is removed, medial smooth muscle cells migrate into sera (APS). Evidence for re-endothelialization was the intima and subsequently proliferate (1, 2). The re- obtained by i.v. Evans blue dye 30 min before sacri- sulting fibromusculoelastic lesion is considered to be fice. Rabbits received daily injections of APS, which a precursor of the characteristic lesion of athero- reduced the mean platelet count to 5,600/cm3; control sclerosis, the fibrous plaque (3, 4). Recently, it has animals received identically treated normal sheep sera been observed that a platelet-derived constituent in on the same schedule, and had mean daily platelet serum is required for growth of arterial smooth muscle counts of 363,000/cm3.
    [Show full text]
  • Adenosine Diphosphate (ADP) Assay Kit (Fluorometric) LS-K202-100 (100 Tests) • Store at -20°C
    Adenosine diphosphate (ADP) Assay Kit (Fluorometric) LS-K202-100 (100 Tests) • Store at -20°C Introduction Adenosine diphosphate (ADP) is the product of ATP dephosphorylation by ATPases. ADP can be converted back to ATP by ATP synthases. ADP levels regulate several enzymes involved in intermediary metabolism. Conventionally, ADP levels are measured by luciferase/luciferin mediated assays after ADP is converted to ATP. However, since these assays require measurement of ATP in the sample before conversion of ADP to ATP, if the nascent ATP concentration is significantly higher than the ADP concentration, the ATP signal will drown out the ADP signal. LSBio’s newly designed ADP Assay Kit provides a convenient fluorometric means to measure ADP level even in the presence of ATP. In the assay, ADP is converted to ATP and pyruvate. The generated pyruvate is then quantified by a fluorometric method (λex/em = 530/590nm). The assay is simple, sensitive, stable, high-throughput adaptable and can detect as low as 0.1 M ADP in biological samples. Key Features • Safe. Non-radioactive assay. • Sensitive and accurate. As low as 0.1 µM ADP can be quantified. • Homogeneous and convenient. "Mix-incubate-measure" type assay. No wash and reagent transfer steps are involved. • Robust and amenable to HTS: Can be readily automated on HTS liquid handling systems for processing thousands of samples per day. Applications • ADP determination in cells and other biological samples. Components K202-100 Component 100 Tests Reagent A 6 mL Reagent B 6 mL Enzyme 120 µL Standard 100 µL 10% TCA 6 mL Neutralizer 1.5 mL Materials Not Supplied Pipetting devices and accessories (e.g.
    [Show full text]
  • Effects of Deoxyadenosine Triphosphate
    [CANCER RESEARCH 40. 3555-3558. October 1980] 0008-5472/80/0040-OOOOS02.00 Effects of Deoxyadenosine Triphosphate and 9-/?-D-Arabinofuranosyl- adenine S'-Triphosphate on Human Ribonucleotide Reducíasefrom Molt-4F Cells and the Concept of "Self-Potentiation"1 Chi-Hsiung Chang2 and Yung-Chi Cheng3 Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill. North Carolina 27514 ABSTRACT conceivable that the intracellular activity of this enzyme is influenced or even regulated by the balance of the steady-state Deoxyadenosine triphosphate (dATP) acted as a noncom level of various nucleotides. That is, changes in pool sizes of petitive inhibitor with respect to the specific nucleoside tri nucleotides could influence the reduction of different ribonu- phosphate activator for the reduction of all four common ribo- cleoside diphosphates and result in changes in deoxyribonu- nucleoside diphosphates catalyzed by the reductase derived cleotide levels. Among the nucleotides examined, ATP acted from human Molt-4F (T-type lymphoblast) cells. The inhibition either as an activator for pyrimidine ribonucleoside diphos constant of dATP for different ribonucleotide reduction reac phate reduction or as an accessory activator for purine ribo tions was different, indicating that the binding of the nucleoside nucleoside diphosphate reduction. dATP is the only nucleotide triphosphate activator or substrate could modify the binding which inhibits reduction of all 4 natural ribonucleotides. The affinity of dATP to the enzyme. dATP also acted as a noncom Ki's (obtained by the replots of intercepts and slopes versus petitive inhibitor with respect to cytidine diphosphate (CDP) for inhibitors) were reported previously (4), but the detailed exper reductase-catalyzed CDP reduction.
    [Show full text]
  • Wo 2009/114533 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 17 September 2009 (17.09.2009) WO 2009/114533 A2 (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/52 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, PCT/US2009/036671 EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (22) International Filing Date: HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, 10 March 2009 (10.03.2009) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, (25) Filing Language: English NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, (26) Publication Language: English SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/035,250 10 March 2008 (10.03.2008) US (84) Designated States (unless otherwise indicated, for every 61/037,145 17 March 2008 (17.03.2008) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (71) Applicant (for all designated States except US): COR¬ ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, NELL UNIVERSITY [US/US]; Cornell Center for TM), European (AT, BE, BG, CH, CY, CZ, DE, DK, EE, Technology, Enterprise & Commercialization, 395 Pine ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, Tree Road, Suite 310, Ithaca, NY 14850 (US).
    [Show full text]